Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Influenza

Free Subscription Articles published in Antiviral Res Retrieve available abstracts of 67 articles: HTML format Text format

Single Articles

April 2012
1. ZU M , Yang F, Zhou W, Liu A, et al
   In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. TAN AC , Eriksson EM, Kedzierska K, Deliyannis G, et al
   Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
3. KIM A , Lee JY, Byun SJ, Kwon MH, et al
   Viral genome RNA degradation by sequence-selective, nucleic-acid hydrolyzing antibody inhibits the replication of influenza H9N2 virus without significant cytotoxicity to host cells.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. THEISEN LL , Muller CP
   EPs(R) 7630 (Umckaloabo(R)), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. TARBET EB , Maekawa M, Furuta Y, Babu YS, et al
   Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
6. MOON HJ , Lee JS, Choi YK, Park JY, et al
   Induction of type I interferon by high-molecular poly-gamma-glutamate protects B6.A2G-Mx1 mice against influenza A virus.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. NGUYEN HT , Trujillo AA, Sheu TG, Levine M, et al
   Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. FERRARIS O , Escuret V, Bouscambert M, Casalegno JS, et al
   H1N1 influenza A virus neuraminidase modulates infectivity in mice.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
9. MENEGHESSO S , Vanderlinden E, Stevaert A, McGuigan C, et al
   Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
   Antiviral Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SHI J , Wen Z, Guo J, Zhang Y, et al
    Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
    Antiviral Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. STONER TD , Krauss S, Turner JC, Seiler P, et al
    Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.
    Antiviral Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
12. KIM M , Yim JH, Kim SY, Kim HS, et al
    In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. IMAI K , Ogawa H, Bui VN, Inoue H, et al
    Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. TARASOV SA , Zarubaev VV, Gorbunov EA, Sergeeva SA, et al
    Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
15. WU WL , Lau SY, Chen Y, Wang G, et al
    The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. WEN J , Zhao S, He D, Yang Y, et al
    Preparation and characterization of egg yolk immunoglobulin Y specific to influenza B virus.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. YOUN HN , Lee DH, Lee YN, Park JK, et al
    Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KUMAR P , Khanna M, Kumar B, Rajput R, et al
    A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
19. ZHANG J , Liu T, Tong X, Li G, et al
    Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. WU Q , Xiao S, Fan H, Li Y, et al
    Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. PAN D , Sun H, Shen Y, Liu H, et al
    Exploring the molecular basis of dsRNA recognition by NS1 protein of influenza A virus using molecular dynamics simulation and free energy calculation.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. ABDUL-CAREEM MF , Firoz Mian M, Gillgrass AE, Chenoweth MJ, et al
    FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. KUMAKI Y , Day CW, Smee DF, Morrey JD, et al
    In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SEVER-CHRONEOS Z , Murthy A, Davis J, Florence JM, et al
    GM-CSF modulates pulmonary resistance to influenza A infection.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. LEE SM , Gai WW, Cheung TK, Peiris JS, et al
    Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
    Antiviral Res. 2011;91:330-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. BANTIA S , Upshaw R, Babu YS
    Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Antiviral Res. 2011;91:288-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
27. JULANDER JG , Hagloch J, Latimer S, Motter N, et al
    Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. WANG W , Zhang P, Hao C, Zhang XE, et al
    In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. DROEBNER K , Pleschka S, Ludwig S, Planz O, et al
    Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
30. ZHIRNOV OP , Klenk HD, Wright PF
    Aprotinin and similar protease inhibitors as drugs against influenza.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. MANCINI N , Solforosi L, Clementi N, De Marco D, et al
    A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. CHEN L , Dou J, Su Z, Zhou H, et al
    Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. MEIJER A , Jonges M, Abbink F, Ang W, et al
    Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. HAASBACH E , Pauli EK, Spranger R, Mitzner D, et al
    Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
35. GIANNECCHINI S , Wise HM, Digard P, Clausi V, et al
    Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. OZAWA T , Jin A, Tajiri K, Takemoto M, et al
    Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. SUDA T , Kawano M, Nogi Y, Ohno N, et al
    The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
38. GOVORKOVA EA , Marathe BM, Prevost A, Rehg JE, et al
    Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. PINTO R , Herold S, Cakarova L, Hoegner K, et al
    Inhibition of influenza virus-induced NF-kappaB and Raf-MEK-ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
40. MOHR PG , Geyer H, McKimm-Breschkin JL
    Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. CHEN HY , Shang YH, Yao HX, Cui BA, et al
    Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. PUZELLI S , Facchini M, Di Martino A, Fabiani C, et al
    Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
43. NIIKURA M , Bance N, Mohan S, Mario Pinto B, et al
    Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. DENG YM , Caldwell N, Hurt A, Shaw T, et al
    A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
45. BANTIA S , Kellogg D, Parker C, Upshaw R, et al
    A Single Intramuscular Injection of Neuraminidase inhibitor Peramivir Demonstrates Antiviral Activity against Novel Pandemic A/California/04/2009 (H1N1) Influenza Virus Infection in Mice.
    Antiviral Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
46. LUNDIN A , Bergstrom T, Bendrioua L, Kann N, et al
    Two novel fusion inhibitors of human respiratory syncytial virus.
    Antiviral Res. 2010;88:317-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. SAKABE S , Iwatsuki-Horimoto K, Horimoto T, Nidom CA, et al
    A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.
    Antiviral Res. 2010;88:249-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
48. JIANG T , Zhao H, Li XF, Deng YQ, et al
    CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. GAROZZO A , Timpanaro R, Stivala A, Bisignano G, et al
    Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8: Study on the mechanism of action.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. DUWE SC , Wedde M, Birkner P, Schweiger B, et al
    Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
51. SVETLIKOVA D , Kabat P, Ohradanova A, Pastorek J, et al
    Influenza A virus replication is inhibited in IFN-lambda2 and IFN -lambda3 transfected or stimulated cells.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. BANTIA S , Kellogg D, Parker CD, Babu YS, et al
    Combination of Peramivir and Rimantadine Demonstrate Synergistic Antiviral Effects in Sub-lethal Influenza A (H3N2) Virus Mouse Model.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
53. YANG JR , Huang YP, Lin YC, Su CH, et al
    Early Findings of Oseltamivir-Resistant Pandemic (H1N1) 2009 Influenza A Viruses in Taiwan.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SONG JM , Kim YC, Barlow PG, Hossain MJ, et al
    Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KIM Y , Narayanan S, Chang KO
    Inhibition of influenza virus replication by plant-derived isoquercetin.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
56. YAVARIAN J , Azad TM, Zheng X, Gregory V, et al
    Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. DHARAN NJ , Beekmann SE, Fiore A, Finelli L, et al
    Influenza Antiviral Prescribing Practices during the 2007-08 and 2008-09 Influenza Seasons in the Setting of Increased Resistance to Oseltamivir among Circulating Influenza Viruses.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. CASALEGNO JS , Bouscambert-Duchamp M, Caro V, Schuffenecker I, et al
    Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.
    Antiviral Res. 2010;87:242-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
59. YOO JK , Baker DP, Fish EN
    Interferon-beta modulates type 1 immunity during influenza virus infection.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. SUNDARARAJAN A , Ganapathy R, Huan L, Dunlap JR, et al
    Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. SMEE DF , Hurst BL, Wong MH, Tarbet EB, et al
    Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. SAHA RK , Takahashi T, Kurebayashi Y, Fukushima K, et al
    Antiviral effect of strictinin on influenza virus replication.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. HURT AC , Lowther S, Middleton D, Barr IG, et al
    Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
64. CASALEGNO JS , Bouscambert-Duchamp M, Caro V, Schuffenecker I, et al
    Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. KUMAR P , Sood V, Vyas R, Gupta N, et al
    Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. CHEN Y , Luo W, Wu WL, Fang Z, et al
    Humanized Antibodies with Broad-Spectrum Neutralization to Avian Influenza Virus H5N1.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
67. WANG B , Dwyer DE, Blyth CC, Soedjono M, et al
    Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
    Antiviral Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: